Showing results (851-860 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|January 7, 2022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer AgentsCharlotte Fenioux, Luis Teixeira, Slim Fourati, et al.
JAMA Oncology|September 11, 2015
Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based StudyChristopher M Booth, Sulaiman Nanji, Xuejiao Wei, et al.
JAMA Oncology|September 11, 2015
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal TestingFrédéric Amant, Magali Verheecke, Iwona Wlodarska, et al.
JAMA Oncology|August 7, 2015
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical TrialSimona F Shaitelman, Pamela J Schlembach, Isidora Arzu, et al.
JAMA Oncology|January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) StudyMarian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
JAMA Oncology|January 30, 2016
Oncofertility and the Rights to Future FertilityEhren M Fournier
JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.
JAMA Oncology|January 10, 2016
Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, CanadaSergio A Acuna, Kimberly A Fernandes, Corinne Daly, et al.
JAMA Oncology|January 23, 2016
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical TrialNicholas D James, Sarah J Pirrie, Ann M Pope, et al.
JAMA Oncology|January 1, 2016
Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer: Role for Immune MonitoringJashodeep Datta, Megan Fracol, Matthew T McMillan, et al.
Pageof 161